BIOMAT Database Logo BIOMAT Database Logo

Alopecia areata in a renal transplant recipient on cyclosporin. 1996

D Dyall-Smith

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000506 Alopecia Areata Loss of scalp and body hair involving microscopically inflammatory patchy areas. Alopecia Circumscripta
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

D Dyall-Smith
Cyclosporin A and alopecia areata.
July 2002, Journal of the European Academy of Dermatology and Venereology : JEADV,
D Dyall-Smith
Topical cyclosporin A in alopecia areata.
January 1989, Acta dermato-venereologica,
D Dyall-Smith
Oral cyclosporin and alopecia areata.
January 1992, Dermatology (Basel, Switzerland),
D Dyall-Smith
Cyclosporin A-related Raynaud's phenomenon in a renal transplant recipient.
October 2002, Transplant international : official journal of the European Society for Organ Transplantation,
D Dyall-Smith
Successful pregnancy in a renal transplant recipient taking cyclosporin A.
February 1983, British medical journal (Clinical research ed.),
D Dyall-Smith
Successful pregnancy in a renal transplant recipient taking cyclosporin A.
December 1986, Australian and New Zealand journal of medicine,
D Dyall-Smith
Cyclosporin-A-induced hair growth in human renal allograft recipients and alopecia areata.
January 1986, Archives of dermatological research,
D Dyall-Smith
Cyclosporin-induced cerebellar syndrome in a pancreatico-renal transplant recipient.
July 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
D Dyall-Smith
Effect of rifampicin on cyclosporin A blood levels in a renal transplant recipient.
January 1985, Nephron,
D Dyall-Smith
Prolonged oliguric renal failure related to cyclosporin A in a renal transplant recipient.
January 1983, American journal of nephrology,
Copied contents to your clipboard!